l 692429 has been researched along with Muscular Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, MA; Fuh, VL | 1 |
1 review(s) available for l 692429 and Muscular Atrophy
| Article | Year |
|---|---|
Growth hormone secretagogues: mechanism of action and use in aging.
Topics: Aged; Aging; Animals; Benzazepines; Double-Blind Method; Female; Frail Elderly; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Indoles; Male; Muscular Atrophy; Oligopeptides; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Somatostatin; Spiro Compounds; Tetrazoles | 1998 |
1 trial(s) available for l 692429 and Muscular Atrophy
| Article | Year |
|---|---|
Growth hormone secretagogues: mechanism of action and use in aging.
Topics: Aged; Aging; Animals; Benzazepines; Double-Blind Method; Female; Frail Elderly; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Indoles; Male; Muscular Atrophy; Oligopeptides; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Somatostatin; Spiro Compounds; Tetrazoles | 1998 |